This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-148a-3p | A4GNT | -0.75 | 0 | -1.24 | 0.00042 | MirTarget | -0.73 | 0 | NA | |
2 | hsa-miR-148a-5p | ABCB5 | -0.77 | 0 | 1.74 | 1.0E-5 | mirMAP | -0.57 | 0 | NA | |
3 | hsa-miR-148a-5p | ABCC5 | -0.77 | 0 | 1.23 | 0 | mirMAP | -0.21 | 0 | NA | |
4 | hsa-miR-148a-5p | ABI2 | -0.77 | 0 | 0.14 | 0.17339 | miRNATAP | -0.24 | 0 | NA | |
5 | hsa-miR-148a-3p | ACHE | -0.75 | 0 | 0.07 | 0.84522 | miRNATAP | -0.64 | 0 | NA | |
6 | hsa-miR-148a-3p | ACSL4 | -0.75 | 0 | 2.07 | 0 | miRNATAP | -0.65 | 0 | NA | |
7 | hsa-miR-148a-5p | ACTG1 | -0.77 | 0 | -0.12 | 0.20938 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
8 | hsa-miR-148a-5p | ACTR3 | -0.77 | 0 | 0.05 | 0.43435 | mirMAP | -0.12 | 0 | NA | |
9 | hsa-miR-148a-3p | ACVR1 | -0.75 | 0 | -0.44 | 1.0E-5 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.13 | 0.0001 | NA | |
10 | hsa-miR-148a-3p | ADAM10 | -0.75 | 0 | -0 | 0.9783 | MirTarget | -0.11 | 0.02275 | NA | |
11 | hsa-miR-148a-3p | ADAM19 | -0.75 | 0 | -0.32 | 0.02321 | mirMAP | -0.33 | 0 | NA | |
12 | hsa-miR-148a-3p | ADAM22 | -0.75 | 0 | 1.17 | 0.00038 | MirTarget; miRNATAP | -0.57 | 0 | NA | |
13 | hsa-miR-148a-3p | ADAM23 | -0.75 | 0 | 1.53 | 0.00013 | MirTarget | -0.47 | 0.00032 | NA | |
14 | hsa-miR-148a-3p | ADAMTS15 | -0.75 | 0 | -0.88 | 0.00206 | MirTarget; miRNATAP | -0.41 | 1.0E-5 | NA | |
15 | hsa-miR-148a-5p | ADAMTS15 | -0.77 | 0 | -0.88 | 0.00206 | mirMAP | -0.4 | 1.0E-5 | NA | |
16 | hsa-miR-148a-3p | ADAMTS18 | -0.75 | 0 | 1.44 | 1.0E-5 | miRNATAP | -0.21 | 0.04667 | NA | |
17 | hsa-miR-148a-3p | ADAMTS5 | -0.75 | 0 | -0.16 | 0.36499 | miRNATAP | -0.31 | 0 | NA | |
18 | hsa-miR-148a-5p | ADAMTS5 | -0.77 | 0 | -0.16 | 0.36499 | mirMAP; miRNATAP | -0.31 | 0 | NA | |
19 | hsa-miR-148a-3p | ADM2 | -0.75 | 0 | 1.72 | 0 | mirMAP | -0.43 | 0 | NA | |
20 | hsa-miR-148a-3p | ADPRH | -0.75 | 0 | -0.13 | 0.2674 | MirTarget | -0.25 | 0 | NA | |
21 | hsa-miR-148a-5p | ADSS | -0.77 | 0 | 0.31 | 0.00033 | MirTarget | -0.11 | 4.0E-5 | NA | |
22 | hsa-miR-148a-5p | AGPAT4 | -0.77 | 0 | 0.87 | 7.0E-5 | mirMAP | -0.25 | 0.00016 | NA | |
23 | hsa-miR-148a-3p | AHDC1 | -0.75 | 0 | -0.23 | 0.02626 | miRNATAP | -0.12 | 0.00053 | NA | |
24 | hsa-miR-148a-5p | ALPK3 | -0.77 | 0 | 1.32 | 0 | mirMAP | -0.3 | 0.00022 | NA | |
25 | hsa-miR-148a-3p | AMZ1 | -0.75 | 0 | -1.28 | 0.00014 | mirMAP | -0.44 | 6.0E-5 | NA | |
26 | hsa-miR-148a-3p | ANK2 | -0.75 | 0 | -0.94 | 8.0E-5 | MirTarget; miRNATAP | -0.44 | 0 | NA | |
27 | hsa-miR-148a-5p | ANK2 | -0.77 | 0 | -0.94 | 8.0E-5 | MirTarget; miRNATAP | -0.3 | 4.0E-5 | NA | |
28 | hsa-miR-148a-3p | ANKRD27 | -0.75 | 0 | 0.9 | 0 | mirMAP | -0.18 | 0 | NA | |
29 | hsa-miR-148a-3p | ANKRD52 | -0.75 | 0 | 1.46 | 0 | mirMAP; miRNATAP | -0.25 | 0 | NA | |
30 | hsa-miR-148a-5p | ANKRD52 | -0.77 | 0 | 1.46 | 0 | miRNATAP | -0.2 | 0 | NA | |
31 | hsa-miR-148a-3p | ANKS6 | -0.75 | 0 | 0.76 | 0.01521 | mirMAP | -0.63 | 0 | NA | |
32 | hsa-miR-148a-3p | ANXA4 | -0.75 | 0 | -0.2 | 0.167 | MirTarget | -0.36 | 0 | NA | |
33 | hsa-miR-106b-5p | APC | 0.65 | 0 | -0.18 | 0.06792 | miRNAWalker2 validate; miRTarBase | -0.15 | 0.00024 | 23087084 | miR 106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma; Moreover we demonstrated that miR-106b downregulates APC expression by directly targeting the 3'-untranslated region of APC messenger RNA; Taken together our results suggest that miR-106b plays an important role in promoting the proliferation of human hepatoma cells and presents a novel mechanism of micro RNA-mediated direct suppression of APC expression in cancer cells |
34 | hsa-miR-21-5p | APC | 1.51 | 0 | -0.18 | 0.06792 | miRNAWalker2 validate | -0.17 | 0 | 23773491; 24832083 | The prognostic significance of APC gene mutation and miR 21 expression in advanced stage colorectal cancer; The aim of this study was to analyse the association of APC gene mutation and miR-21 expression with clinical outcome in CRC patients; APC gene mutation and expression of APC and miR-21 were analysed by direct DNA sequencing and real-time reverse transcription polymerase chain reaction; APC gene expression was low in CRC and negatively correlated with miR-21 expression and gene mutation; In Taiwan downregulation of the APC gene in CRC correlated with gene mutation and miR-21 upregulation; APC mutation and miR-21 expression could be used to predict the clinical outcome of CRC especially in patients with advanced disease;MicroRNA 21 promotes tumour malignancy via increased nuclear translocation of β catenin and predicts poor outcome in APC mutated but not in APC wild type colorectal cancer; However in our preliminary data the prognostic value of miR-21 levels was observed only in adenomatous polyposis coli APC-mutated tumours not in APC-wild-type tumours; We enrolled 165 colorectal tumour to determine APC mutation miR-21 levels and nuclear β-catenin expression by direct sequencing real-time PCR and immunohistochemistry |
35 | hsa-miR-148a-3p | ARAP2 | -0.75 | 0 | -1.13 | 0 | MirTarget | -0.26 | 0 | NA | |
36 | hsa-miR-148a-5p | ARHGAP31 | -0.77 | 0 | -0.42 | 0.00347 | mirMAP | -0.14 | 0.00129 | NA | |
37 | hsa-miR-103a-3p | ARHGAP5 | 0.77 | 0 | -0.39 | 8.0E-5 | MirTarget | -0.19 | 1.0E-5 | NA | |
38 | hsa-miR-155-5p | ARHGAP5 | 0.01 | 0.95651 | -0.39 | 8.0E-5 | mirMAP | -0.11 | 1.0E-5 | NA | |
39 | hsa-miR-15a-5p | ARHGAP5 | 0.35 | 0.00077 | -0.39 | 8.0E-5 | MirTarget; miRNATAP | -0.14 | 0.00276 | NA | |
40 | hsa-miR-16-1-3p | ARHGAP5 | 0.39 | 0.00112 | -0.39 | 8.0E-5 | MirTarget | -0.11 | 0.00823 | NA | |
41 | hsa-miR-17-5p | ARHGAP5 | 0.7 | 2.0E-5 | -0.39 | 8.0E-5 | miRNAWalker2 validate | -0.17 | 0 | NA | |
42 | hsa-miR-181a-5p | ARHGAP5 | 0.25 | 0.05519 | -0.39 | 8.0E-5 | mirMAP | -0.18 | 0 | NA | |
43 | hsa-miR-181b-5p | ARHGAP5 | 0.49 | 0.00105 | -0.39 | 8.0E-5 | mirMAP | -0.16 | 0 | NA | |
44 | hsa-miR-18a-5p | ARHGAP5 | 0.92 | 2.0E-5 | -0.39 | 8.0E-5 | MirTarget | -0.14 | 0 | NA | |
45 | hsa-miR-19a-3p | ARHGAP5 | 1.02 | 0 | -0.39 | 8.0E-5 | miRNATAP | -0.1 | 2.0E-5 | NA | |
46 | hsa-miR-19b-3p | ARHGAP5 | 0.6 | 0.00017 | -0.39 | 8.0E-5 | miRNATAP | -0.13 | 3.0E-5 | NA | |
47 | hsa-miR-421 | ARHGAP5 | 0.94 | 0 | -0.39 | 8.0E-5 | PITA; miRanda; mirMAP; miRNATAP | -0.1 | 0.00026 | NA | |
48 | hsa-miR-500a-5p | ARHGAP5 | 0.8 | 0 | -0.39 | 8.0E-5 | mirMAP | -0.13 | 4.0E-5 | NA | |
49 | hsa-miR-501-5p | ARHGAP5 | 1.15 | 0 | -0.39 | 8.0E-5 | PITA; mirMAP | -0.14 | 0 | NA | |
50 | hsa-miR-590-5p | ARHGAP5 | -0.1 | 0.31003 | -0.39 | 8.0E-5 | miRanda | -0.13 | 0.00897 | NA | |
51 | hsa-miR-148a-3p | ARHGEF17 | -0.75 | 0 | 0.06 | 0.69914 | miRNATAP | -0.46 | 0 | NA | |
52 | hsa-miR-148a-5p | ARHGEF18 | -0.77 | 0 | 0.5 | 0 | MirTarget; miRNATAP | -0.12 | 0 | NA | |
53 | hsa-miR-148a-5p | ARID5B | -0.77 | 0 | -0.52 | 0.00012 | mirMAP | -0.17 | 3.0E-5 | NA | |
54 | hsa-miR-148a-5p | ASAH1 | -0.77 | 0 | -0.44 | 0.00056 | MirTarget; miRNATAP | -0.22 | 0 | NA | |
55 | hsa-miR-148a-3p | ATG4D | -0.75 | 0 | 0.24 | 0.03588 | MirTarget | -0.18 | 0 | NA | |
56 | hsa-miR-148a-3p | ATP11A | -0.75 | 0 | 0.19 | 0.15998 | MirTarget | -0.17 | 0.00011 | NA | |
57 | hsa-miR-148a-3p | ATP2B4 | -0.75 | 0 | 0.27 | 0.06736 | MirTarget; miRNATAP | -0.11 | 0.02111 | NA | |
58 | hsa-miR-148a-3p | ATP7A | -0.75 | 0 | 0.25 | 0.01885 | MirTarget; miRNATAP | -0.12 | 0.00074 | NA | |
59 | hsa-miR-148a-3p | AURKB | -0.75 | 0 | 3.49 | 0 | miRNAWalker2 validate | -0.53 | 0 | NA | |
60 | hsa-let-7b-3p | AXIN2 | -1.22 | 0 | 0.11 | 0.75298 | miRNATAP | -0.27 | 0.0205 | NA | |
61 | hsa-let-7g-3p | AXIN2 | -1.14 | 0 | 0.11 | 0.75298 | MirTarget | -0.33 | 0.01126 | NA | |
62 | hsa-miR-15b-5p | AXIN2 | 0.23 | 0.08248 | 0.11 | 0.75298 | miRTarBase; MirTarget; miRNATAP | -0.45 | 0.00081 | NA | |
63 | hsa-miR-16-2-3p | AXIN2 | -0.03 | 0.80516 | 0.11 | 0.75298 | mirMAP | -0.64 | 0 | NA | |
64 | hsa-miR-16-5p | AXIN2 | -0.4 | 0.0001 | 0.11 | 0.75298 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.49 | 0.00421 | NA | |
65 | hsa-miR-195-3p | AXIN2 | -1.09 | 0 | 0.11 | 0.75298 | mirMAP | -0.31 | 0.00083 | NA | |
66 | hsa-miR-195-5p | AXIN2 | -1.86 | 0 | 0.11 | 0.75298 | MirTarget; miRNATAP | -0.25 | 0.00506 | NA | |
67 | hsa-miR-26b-3p | AXIN2 | -1.26 | 0 | 0.11 | 0.75298 | MirTarget | -0.59 | 3.0E-5 | NA | |
68 | hsa-miR-326 | AXIN2 | -1.88 | 0 | 0.11 | 0.75298 | miRanda | -0.36 | 2.0E-5 | NA | |
69 | hsa-miR-338-5p | AXIN2 | -0.22 | 0.25239 | 0.11 | 0.75298 | miRNATAP | -0.34 | 0.00017 | NA | |
70 | hsa-miR-424-5p | AXIN2 | -2.63 | 0 | 0.11 | 0.75298 | MirTarget; miRNATAP | -0.19 | 0.03018 | NA | |
71 | hsa-miR-497-5p | AXIN2 | -1.41 | 0 | 0.11 | 0.75298 | MirTarget; miRNATAP | -0.29 | 0.00329 | NA | |
72 | hsa-miR-616-3p | AXIN2 | -0.7 | 2.0E-5 | 0.11 | 0.75298 | MirTarget | -0.42 | 8.0E-5 | NA | |
73 | hsa-miR-148a-3p | B4GALT2 | -0.75 | 0 | 0.26 | 0.00786 | miRNATAP | -0.13 | 3.0E-5 | NA | |
74 | hsa-miR-148a-3p | B4GALT5 | -0.75 | 0 | -0.52 | 0 | MirTarget; miRNATAP | -0.33 | 0 | NA | |
75 | hsa-miR-148a-3p | BAZ2A | -0.75 | 0 | 0.46 | 0 | mirMAP; miRNATAP | -0.15 | 0 | NA | |
76 | hsa-miR-148a-3p | BCL2 | -0.75 | 0 | -0.35 | 0.02497 | miRNAWalker2 validate; miRTarBase | -0.31 | 0 | 21455217; 23975374 | MiR 148a promotes apoptosis by targeting Bcl 2 in colorectal cancer;MiR 148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl 2; Using western blot and luciferase activity assay CCKBR and Bcl-2 were identified as targets of miR-148a; Moreover we also found that the expression of Bcl-2 lacking in 3'UTR could abrogate the pro-apoptosis function of miR-148a |
77 | hsa-miR-148a-3p | BCL9L | -0.75 | 0 | 0.49 | 7.0E-5 | mirMAP | -0.25 | 0 | NA | |
78 | hsa-miR-148a-5p | BDNF | -0.77 | 0 | 0.05 | 0.83189 | mirMAP | -0.26 | 0.00044 | NA | |
79 | hsa-miR-148a-3p | BHLHE41 | -0.75 | 0 | -0.4 | 0.15906 | MirTarget | -0.82 | 0 | NA | |
80 | hsa-miR-148a-5p | BICD1 | -0.77 | 0 | 0.8 | 0.0004 | mirMAP | -0.4 | 0 | NA | |
81 | hsa-let-7b-5p | BIRC5 | -0.96 | 0 | 4.5 | 0 | miRNAWalker2 validate | -0.71 | 0 | NA | |
82 | hsa-miR-101-3p | BIRC5 | -1.48 | 0 | 4.5 | 0 | miRNAWalker2 validate | -1.33 | 0 | NA | |
83 | hsa-miR-10a-5p | BIRC5 | -1.48 | 0 | 4.5 | 0 | miRNAWalker2 validate | -0.71 | 0 | NA | |
84 | hsa-miR-203a-3p | BIRC5 | -1.34 | 9.0E-5 | 4.5 | 0 | miRTarBase | -0.13 | 0.00935 | 22713668; 27714672 | Luciferase assays were also performed to validate BIRC5 and LASP1 as miR-203 targets; Both miR-203 and BIRC5 siRNA signicantly inhibited cell proliferation in TNBC cells; Moreover up-regulated of BIRC5 and LASP1 was able to abrogate the effects induced by transfection with the miR-203 precursor;miR 203 is a predictive biomarker for colorectal cancer and its expression is associated with BIRC5; The purpose of this study was to explore the role of miR-203 in colorectal cancer CRC and evaluate the correlation between miR-203 and BIRC5; Finally miR-203 expression was negatively associated with that of BIRC5 r = -0.8150 P < 0.05 |
85 | hsa-miR-218-5p | BIRC5 | -0.5 | 0.03986 | 4.5 | 0 | miRTarBase; MirTarget | -0.14 | 0.03933 | 25473903; 25900794; 26442524 | Survivin BIRC5 was subsequently identified as an important cervical cancer target of miR-218 using in silico prediction mRNA profiling and quantitative real-time PCR qRT-PCR;miR-218 binds survivin BIRC5 mRNA 3'-UTR and down-regulated reporter luciferase activity;MiR-218 promoted apoptosis inhibited cell proliferation and caused cell cycle arrest in CRC cells by suppressing BIRC5 expression; In conclusion we demonstrated that high miR-218 expression had a positive prognostic value in 5-FU-based treatments for CRC patients and discovered a novel mechanism mediated by miR-218 to promote apoptosis and to function synergistically with 5-FU to promote chemosensitivity by suppressing BIRC5 and TS in CRC |
86 | hsa-miR-30c-5p | BIRC5 | -0.43 | 0.00016 | 4.5 | 0 | miRNAWalker2 validate | -0.45 | 0.00191 | NA | |
87 | hsa-miR-335-5p | BIRC5 | -1.61 | 0 | 4.5 | 0 | miRNAWalker2 validate; MirTarget | -0.5 | 0 | 23232114 | Genetic variation in a miR 335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations; In support of the postulation that the 3' UTR SNP may directly affect miRNA-binding site reporter gene assays indicated BIRC5 was a direct target of miR-335 and the rs2239680 T>C change resulted in altered regulation of BIRC5 expression; Our findings defined a 3' UTR SNP in human BIRC5 oncogene that may increase individual susceptibility to lung cancer probably by attenuating the interaction between miR-335 and BIRC5 |
88 | hsa-miR-542-3p | BIRC5 | -1.31 | 0 | 4.5 | 0 | miRNAWalker2 validate; MirTarget; miRanda | -0.82 | 0 | NA | |
89 | hsa-miR-148a-3p | BMF | -0.75 | 0 | 0.48 | 0.01823 | mirMAP | -0.31 | 0 | NA | |
90 | hsa-miR-148a-3p | BTBD10 | -0.75 | 0 | 0.28 | 2.0E-5 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
91 | hsa-miR-148a-3p | BTBD3 | -0.75 | 0 | 0.3 | 0.00861 | miRNAWalker2 validate; miRNATAP | -0.17 | 1.0E-5 | NA | |
92 | hsa-miR-139-5p | BUB1 | -2.11 | 0 | 4.05 | 0 | miRanda | -0.98 | 0 | NA | |
93 | hsa-miR-199a-5p | BUB1 | -1.99 | 0 | 4.05 | 0 | miRanda | -0.29 | 0 | NA | |
94 | hsa-miR-542-3p | BUB1 | -1.31 | 0 | 4.05 | 0 | miRanda | -0.67 | 0 | NA | |
95 | hsa-miR-142-3p | BUB1B | -1.42 | 0 | 3.86 | 0 | miRanda | -0.2 | 0.01193 | NA | |
96 | hsa-miR-192-5p | BUB1B | -0.5 | 0.00345 | 3.86 | 0 | miRNAWalker2 validate | -0.22 | 0.01192 | NA | |
97 | hsa-miR-193b-3p | BUB1B | -0.17 | 0.27202 | 3.86 | 0 | miRNAWalker2 validate | -0.2 | 0.04744 | NA | |
98 | hsa-miR-215-5p | BUB1B | -0.98 | 3.0E-5 | 3.86 | 0 | miRNAWalker2 validate | -0.16 | 0.00993 | NA | |
99 | hsa-miR-22-3p | BUB1B | -0.63 | 0 | 3.86 | 0 | miRNAWalker2 validate | -1.6 | 0 | NA | |
100 | hsa-miR-486-5p | BUB1B | -1.78 | 0 | 3.86 | 0 | miRanda | -0.42 | 0 | NA | |
101 | hsa-miR-148a-3p | C1orf116 | -0.75 | 0 | -1.07 | 0.0053 | mirMAP | -0.61 | 0 | NA | |
102 | hsa-miR-148a-5p | C3orf14 | -0.77 | 0 | -0.24 | 0.47117 | mirMAP | -0.29 | 0.00417 | NA | |
103 | hsa-miR-148a-5p | C5AR1 | -0.77 | 0 | -1.17 | 0 | mirMAP | -0.18 | 0.00087 | NA | |
104 | hsa-miR-148a-3p | C5orf30 | -0.75 | 0 | 0.91 | 0.00049 | miRNATAP | -0.74 | 0 | NA | |
105 | hsa-miR-148a-5p | CA12 | -0.77 | 0 | 2.34 | 0 | MirTarget | -0.98 | 0 | NA | |
106 | hsa-miR-148a-5p | CACNA1D | -0.77 | 0 | 0.08 | 0.77567 | MirTarget; miRNATAP | -0.49 | 0 | NA | |
107 | hsa-miR-148a-3p | CACNA1E | -0.75 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.55 | 2.0E-5 | NA | |
108 | hsa-miR-148a-5p | CACNA1E | -0.77 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.5 | 3.0E-5 | NA | |
109 | hsa-miR-148a-3p | CASZ1 | -0.75 | 0 | 0.04 | 0.75925 | miRNATAP | -0.22 | 0 | NA | |
110 | hsa-miR-148a-3p | CBFA2T2 | -0.75 | 0 | 1.21 | 0 | mirMAP | -0.14 | 8.0E-5 | NA | |
111 | hsa-miR-148a-5p | CBFA2T2 | -0.77 | 0 | 1.21 | 0 | mirMAP | -0.11 | 0.00103 | NA | |
112 | hsa-miR-148a-3p | CBX5 | -0.75 | 0 | 0.35 | 0.00158 | mirMAP | -0.15 | 2.0E-5 | NA | |
113 | hsa-miR-148a-3p | CCDC6 | -0.75 | 0 | 0.05 | 0.48713 | MirTarget | -0.16 | 0 | NA | |
114 | hsa-miR-148a-5p | CCDC6 | -0.77 | 0 | 0.05 | 0.48713 | MirTarget | -0.13 | 0 | NA | |
115 | hsa-miR-148a-3p | CCDC85A | -0.75 | 0 | 0.74 | 9.0E-5 | miRNATAP | -0.16 | 0.00895 | NA | |
116 | hsa-miR-148a-5p | CCDC93 | -0.77 | 0 | 1.03 | 0 | mirMAP | -0.16 | 0 | NA | |
117 | hsa-let-7a-3p | CCNA2 | -0.57 | 0 | 3.37 | 0 | MirTarget | -0.51 | 4.0E-5 | NA | |
118 | hsa-let-7b-3p | CCNA2 | -1.22 | 0 | 3.37 | 0 | MirTarget | -0.73 | 0 | NA | |
119 | hsa-let-7b-5p | CCNA2 | -0.96 | 0 | 3.37 | 0 | miRNAWalker2 validate; miRTarBase | -0.52 | 0 | NA | |
120 | hsa-let-7f-1-3p | CCNA2 | -0.7 | 0 | 3.37 | 0 | MirTarget | -0.41 | 1.0E-5 | NA | |
121 | hsa-miR-130a-3p | CCNA2 | -1.53 | 0 | 3.37 | 0 | miRNATAP | -0.39 | 0 | NA | |
122 | hsa-miR-199a-5p | CCNA2 | -1.99 | 0 | 3.37 | 0 | miRanda | -0.27 | 0 | NA | |
123 | hsa-miR-22-3p | CCNA2 | -0.63 | 0 | 3.37 | 0 | MirTarget | -1.22 | 0 | 25596928 | The sequence of miR-22 which is conserved in mice rats humans and other mammalians aligns with the sequence of 3'-UTR of CCNA2; Chenodeoxycholic acid treatment and miR-22 mimics reduced CCNA2 protein and increased the number of G0/G1 Huh7 and HCT116 cells; In humans the expression levels of miR-22 and CCNA2 are inversely correlated in liver and colon cancers |
124 | hsa-miR-27b-3p | CCNA2 | -0.82 | 0 | 3.37 | 0 | miRNATAP | -0.54 | 0 | NA | |
125 | hsa-miR-29a-3p | CCNA2 | -0.86 | 0 | 3.37 | 0 | MirTarget | -0.88 | 0 | NA | |
126 | hsa-miR-29b-1-5p | CCNA2 | -0.54 | 0.00103 | 3.37 | 0 | MirTarget | -0.33 | 4.0E-5 | NA | |
127 | hsa-miR-29b-3p | CCNA2 | -0.35 | 0.01214 | 3.37 | 0 | MirTarget | -0.59 | 0 | NA | |
128 | hsa-miR-29c-3p | CCNA2 | -1.44 | 0 | 3.37 | 0 | MirTarget | -0.92 | 0 | NA | |
129 | hsa-miR-374b-5p | CCNA2 | -0.31 | 0.00301 | 3.37 | 0 | mirMAP | -0.33 | 0.01143 | NA | |
130 | hsa-miR-486-5p | CCNA2 | -1.78 | 0 | 3.37 | 0 | miRanda | -0.28 | 0 | NA | |
131 | hsa-let-7b-5p | CCNB1 | -0.96 | 0 | 3.16 | 0 | miRNAWalker2 validate | -0.54 | 0 | NA | |
132 | hsa-miR-139-5p | CCNB1 | -2.11 | 0 | 3.16 | 0 | miRanda | -0.8 | 0 | NA | |
133 | hsa-miR-142-5p | CCNB1 | -1.45 | 0 | 3.16 | 0 | MirTarget | -0.15 | 0.01528 | NA | |
134 | hsa-miR-148a-3p | CCT6A | -0.75 | 0 | 0.81 | 0 | MirTarget | -0.14 | 0 | NA | |
135 | hsa-miR-148a-5p | CD109 | -0.77 | 0 | 1.84 | 0 | mirMAP | -0.35 | 4.0E-5 | NA | |
136 | hsa-miR-148a-5p | CD2AP | -0.77 | 0 | 0.18 | 0.04226 | mirMAP | -0.14 | 0 | NA | |
137 | hsa-miR-148a-5p | CD44 | -0.77 | 0 | -0.09 | 0.71793 | mirMAP | -0.31 | 2.0E-5 | 23861222 | In MHCC97H and MHCC97L cells over-expression of miR-148a blocked the EMT process attenuated the expression of CD90 and CD44 biomarkers for liver cancer stem cells and inhibited their migratory capacity |
138 | hsa-miR-148a-5p | CD93 | -0.77 | 0 | 0.15 | 0.24648 | mirMAP | -0.24 | 0 | NA | |
139 | hsa-miR-192-5p | CDC20 | -0.5 | 0.00345 | 4.44 | 0 | miRNAWalker2 validate | -0.26 | 0.00747 | NA | |
140 | hsa-miR-215-5p | CDC20 | -0.98 | 3.0E-5 | 4.44 | 0 | miRNAWalker2 validate | -0.21 | 0.0025 | NA | |
141 | hsa-miR-23b-3p | CDC20 | -0.53 | 0 | 4.44 | 0 | miRNAWalker2 validate | -0.73 | 0 | NA | |
142 | hsa-miR-30a-5p | CDC20 | -0.63 | 0.00011 | 4.44 | 0 | miRNAWalker2 validate | -0.69 | 0 | NA | |
143 | hsa-miR-29c-3p | CDC23 | -1.44 | 0 | 0.46 | 0 | miRNAWalker2 validate | -0.14 | 0 | NA | |
144 | hsa-miR-148a-3p | CDC25B | -0.75 | 0 | 0.8 | 0 | miRNAWalker2 validate; miRNATAP | -0.29 | 0 | 25341915 | Gene CDC25B might be the target gene of miR-148a according to the results of targetscan; CDC25B may be the target gene of miR-148a that plays a role in tumor suppressor |
145 | hsa-miR-146b-5p | CDH1 | 0.42 | 0.04574 | -0.93 | 4.0E-5 | miRanda | -0.21 | 6.0E-5 | NA | |
146 | hsa-miR-185-5p | CDH1 | 0.48 | 0 | -0.93 | 4.0E-5 | MirTarget | -0.45 | 8.0E-5 | 27212161; 24025511 | We also found that ectopic expression of miR-185 reversed EMT via the up-regulation of E-cadherin and down-regulation of vimentin in epithelial and mesenchymal HCC cells;After transfection of miR-185 inhibitor into KYSE30 the expression of E-cadherin a downstream protein of Six1 was observed under confocal microscope; After transfection of miR-185 inhibitorthe expression level of E-cadherin decreased |
147 | hsa-miR-186-5p | CDH1 | -0.06 | 0.53529 | -0.93 | 4.0E-5 | mirMAP | -0.27 | 0.01827 | NA | |
148 | hsa-miR-616-5p | CDH1 | 0.15 | 0.40284 | -0.93 | 4.0E-5 | MirTarget; mirMAP | -0.14 | 0.02086 | NA | |
149 | hsa-miR-139-5p | CDK1 | -2.11 | 0 | 3.6 | 0 | miRanda | -0.84 | 0 | NA | |
150 | hsa-miR-193b-3p | CDK1 | -0.17 | 0.27202 | 3.6 | 0 | miRNAWalker2 validate | -0.25 | 0.00582 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 104 | 1672 | 2.052e-19 | 9.547e-16 |
2 | REGULATION OF CELL DIFFERENTIATION | 96 | 1492 | 7.162e-19 | 1.666e-15 |
3 | PROTEIN PHOSPHORYLATION | 73 | 944 | 1.236e-18 | 1.917e-15 |
4 | NEUROGENESIS | 90 | 1402 | 1.298e-17 | 1.51e-14 |
5 | TISSUE DEVELOPMENT | 94 | 1518 | 2.227e-17 | 2.072e-14 |
6 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 70 | 957 | 1.296e-16 | 1.005e-13 |
7 | CELL DEVELOPMENT | 88 | 1426 | 3.569e-16 | 2.372e-13 |
8 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 81 | 1275 | 1.323e-15 | 7.697e-13 |
9 | TISSUE MORPHOGENESIS | 48 | 533 | 5.552e-15 | 2.87e-12 |
10 | MORPHOGENESIS OF AN EPITHELIUM | 41 | 400 | 7.758e-15 | 3.61e-12 |
11 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 58 | 788 | 5.346e-14 | 2.073e-11 |
12 | CIRCULATORY SYSTEM DEVELOPMENT | 58 | 788 | 5.346e-14 | 2.073e-11 |
13 | LOCOMOTION | 71 | 1114 | 8.433e-14 | 3.018e-11 |
14 | EPITHELIUM DEVELOPMENT | 64 | 945 | 1.092e-13 | 3.63e-11 |
15 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 67 | 1021 | 1.195e-13 | 3.706e-11 |
16 | PHOSPHORYLATION | 75 | 1228 | 1.342e-13 | 3.903e-11 |
17 | REGULATION OF CELL DEVELOPMENT | 59 | 836 | 1.945e-13 | 5.323e-11 |
18 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 71 | 1142 | 2.825e-13 | 7.303e-11 |
19 | NEURON DIFFERENTIATION | 60 | 874 | 3.92e-13 | 9.121e-11 |
20 | REGULATION OF CELL PROLIFERATION | 84 | 1496 | 3.733e-13 | 9.121e-11 |
21 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 79 | 1395 | 1.386e-12 | 2.938e-10 |
22 | TUBE DEVELOPMENT | 45 | 552 | 1.389e-12 | 2.938e-10 |
23 | NEURON PROJECTION DEVELOPMENT | 44 | 545 | 3.47e-12 | 7.021e-10 |
24 | INTRACELLULAR SIGNAL TRANSDUCTION | 84 | 1572 | 5.213e-12 | 1.011e-09 |
25 | CELL MOTILITY | 56 | 835 | 6.502e-12 | 1.164e-09 |
26 | LOCALIZATION OF CELL | 56 | 835 | 6.502e-12 | 1.164e-09 |
27 | TUBE MORPHOGENESIS | 32 | 323 | 1.893e-11 | 3.262e-09 |
28 | REGULATION OF CELL ADHESION | 46 | 629 | 3.28e-11 | 5.451e-09 |
29 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 56 | 872 | 3.523e-11 | 5.653e-09 |
30 | CELLULAR COMPONENT MORPHOGENESIS | 57 | 900 | 3.981e-11 | 6.175e-09 |
31 | ORGAN MORPHOGENESIS | 54 | 841 | 8.208e-11 | 1.193e-08 |
32 | NEURON PROJECTION MORPHOGENESIS | 35 | 402 | 7.989e-11 | 1.193e-08 |
33 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 40 | 513 | 1.007e-10 | 1.42e-08 |
34 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 50 | 750 | 1.186e-10 | 1.622e-08 |
35 | CELL PROJECTION ORGANIZATION | 56 | 902 | 1.28e-10 | 1.657e-08 |
36 | BIOLOGICAL ADHESION | 61 | 1032 | 1.282e-10 | 1.657e-08 |
37 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 94 | 1977 | 1.496e-10 | 1.882e-08 |
38 | NEURON PROJECTION GUIDANCE | 24 | 205 | 2.202e-10 | 2.696e-08 |
39 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 87 | 1791 | 2.923e-10 | 3.487e-08 |
40 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 52 | 823 | 3.354e-10 | 3.902e-08 |
41 | BLOOD VESSEL MORPHOGENESIS | 32 | 364 | 4.143e-10 | 4.702e-08 |
42 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 32 | 368 | 5.457e-10 | 6.045e-08 |
43 | POSITIVE REGULATION OF GENE EXPRESSION | 84 | 1733 | 7.032e-10 | 7.609e-08 |
44 | REGULATION OF NEURON DIFFERENTIATION | 40 | 554 | 9.791e-10 | 1.035e-07 |
45 | VASCULATURE DEVELOPMENT | 36 | 469 | 1.377e-09 | 1.423e-07 |
46 | HEAD DEVELOPMENT | 46 | 709 | 1.642e-09 | 1.661e-07 |
47 | NEURON DEVELOPMENT | 45 | 687 | 1.858e-09 | 1.839e-07 |
48 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 45 | 689 | 2.033e-09 | 1.971e-07 |
49 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 48 | 771 | 2.729e-09 | 2.591e-07 |
50 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 30 | 352 | 3.065e-09 | 2.852e-07 |
51 | ANGIOGENESIS | 27 | 293 | 3.601e-09 | 3.286e-07 |
52 | REGULATION OF PROTEIN MODIFICATION PROCESS | 81 | 1710 | 4.34e-09 | 3.884e-07 |
53 | POSITIVE REGULATION OF CELL PROLIFERATION | 49 | 814 | 5.525e-09 | 4.85e-07 |
54 | EMBRYO DEVELOPMENT | 52 | 894 | 5.815e-09 | 4.92e-07 |
55 | POSITIVE REGULATION OF CELL DEVELOPMENT | 35 | 472 | 5.749e-09 | 4.92e-07 |
56 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 83 | 1784 | 6.172e-09 | 5.128e-07 |
57 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 74 | 1518 | 6.86e-09 | 5.6e-07 |
58 | MUSCLE STRUCTURE DEVELOPMENT | 33 | 432 | 7.682e-09 | 6.163e-07 |
59 | EXTRACELLULAR STRUCTURE ORGANIZATION | 27 | 304 | 7.961e-09 | 6.279e-07 |
60 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 26 | 285 | 8.682e-09 | 6.733e-07 |
61 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 77 | 1618 | 9.196e-09 | 7.015e-07 |
62 | CONNECTIVE TISSUE DEVELOPMENT | 21 | 194 | 1.225e-08 | 9.192e-07 |
63 | HEART DEVELOPMENT | 34 | 466 | 1.429e-08 | 1.055e-06 |
64 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 28 | 337 | 1.804e-08 | 1.311e-06 |
65 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 77 | 1656 | 2.484e-08 | 1.778e-06 |
66 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 59 | 1135 | 3.092e-08 | 2.18e-06 |
67 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 32 | 437 | 3.532e-08 | 2.453e-06 |
68 | CELL PART MORPHOGENESIS | 40 | 633 | 4.128e-08 | 2.825e-06 |
69 | REGULATION OF CELL DEATH | 70 | 1472 | 4.987e-08 | 3.363e-06 |
70 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 39 | 616 | 5.839e-08 | 3.881e-06 |
71 | ACTIN FILAMENT BASED PROCESS | 32 | 450 | 6.968e-08 | 4.567e-06 |
72 | CELL PROLIFERATION | 41 | 672 | 7.27e-08 | 4.699e-06 |
73 | REGULATION OF TRANSFERASE ACTIVITY | 51 | 946 | 9.426e-08 | 6.008e-06 |
74 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 36 | 554 | 1.014e-07 | 6.378e-06 |
75 | NEGATIVE REGULATION OF CELL DEATH | 48 | 872 | 1.248e-07 | 7.74e-06 |
76 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 16 | 131 | 1.264e-07 | 7.74e-06 |
77 | RESPONSE TO ENDOGENOUS STIMULUS | 68 | 1450 | 1.346e-07 | 8.137e-06 |
78 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 25 | 306 | 1.458e-07 | 8.699e-06 |
79 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 79 | 1805 | 2.031e-07 | 1.196e-05 |
80 | CYTOSKELETON ORGANIZATION | 46 | 838 | 2.515e-07 | 1.463e-05 |
81 | REGULATION OF CELL CYCLE | 50 | 949 | 2.552e-07 | 1.466e-05 |
82 | TRACHEA DEVELOPMENT | 7 | 20 | 2.864e-07 | 1.625e-05 |
83 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 51 | 983 | 3.068e-07 | 1.72e-05 |
84 | NEGATIVE REGULATION OF CELL CYCLE | 30 | 433 | 3.148e-07 | 1.744e-05 |
85 | UROGENITAL SYSTEM DEVELOPMENT | 24 | 299 | 3.583e-07 | 1.961e-05 |
86 | CELL DIVISION | 31 | 460 | 3.654e-07 | 1.977e-05 |
87 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 82 | 1929 | 3.859e-07 | 2.064e-05 |
88 | NEGATIVE REGULATION OF GENE EXPRESSION | 68 | 1493 | 3.958e-07 | 2.093e-05 |
89 | RAS PROTEIN SIGNAL TRANSDUCTION | 16 | 143 | 4.273e-07 | 2.234e-05 |
90 | TAXIS | 31 | 464 | 4.407e-07 | 2.278e-05 |
91 | POSITIVE REGULATION OF CELL COMMUNICATION | 69 | 1532 | 4.842e-07 | 2.465e-05 |
92 | REGULATION OF KINASE ACTIVITY | 43 | 776 | 4.919e-07 | 2.465e-05 |
93 | NEGATIVE REGULATION OF CELL PROLIFERATION | 38 | 643 | 4.927e-07 | 2.465e-05 |
94 | SYNAPSE ORGANIZATION | 16 | 145 | 5.168e-07 | 2.558e-05 |
95 | SENSORY ORGAN DEVELOPMENT | 32 | 493 | 5.424e-07 | 2.657e-05 |
96 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 52 | 1036 | 6.389e-07 | 3.065e-05 |
97 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 52 | 1036 | 6.389e-07 | 3.065e-05 |
98 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 51 | 1008 | 6.519e-07 | 3.095e-05 |
99 | FOREBRAIN DEVELOPMENT | 26 | 357 | 7.643e-07 | 3.592e-05 |
100 | REGULATION OF CELL MORPHOGENESIS | 34 | 552 | 7.937e-07 | 3.693e-05 |
101 | REGULATION OF CELL CYCLE PROCESS | 34 | 558 | 1.013e-06 | 4.62e-05 |
102 | CELL CYCLE PROCESS | 53 | 1081 | 1.008e-06 | 4.62e-05 |
103 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 43 | 799 | 1.066e-06 | 4.815e-05 |
104 | SKIN EPIDERMIS DEVELOPMENT | 11 | 71 | 1.093e-06 | 4.889e-05 |
105 | LUNG MORPHOGENESIS | 9 | 45 | 1.136e-06 | 4.995e-05 |
106 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 43 | 801 | 1.138e-06 | 4.995e-05 |
107 | REGULATION OF VASCULATURE DEVELOPMENT | 20 | 233 | 1.2e-06 | 5.22e-05 |
108 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 36 | 616 | 1.288e-06 | 5.551e-05 |
109 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 50 | 1004 | 1.337e-06 | 5.707e-05 |
110 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 55 | 1152 | 1.407e-06 | 5.95e-05 |
111 | MUSCLE CELL DIFFERENTIATION | 20 | 237 | 1.565e-06 | 6.561e-05 |
112 | SPINDLE CHECKPOINT | 7 | 25 | 1.598e-06 | 6.637e-05 |
113 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 66 | 1492 | 1.654e-06 | 6.811e-05 |
114 | PEPTIDYL AMINO ACID MODIFICATION | 44 | 841 | 1.68e-06 | 6.855e-05 |
115 | REGULATION OF OSSIFICATION | 17 | 178 | 1.769e-06 | 7.158e-05 |
116 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 77 | 1848 | 2.001e-06 | 8.025e-05 |
117 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 45 | 876 | 2.072e-06 | 8.242e-05 |
118 | RESPONSE TO GROWTH FACTOR | 30 | 475 | 2.155e-06 | 8.497e-05 |
119 | KIDNEY EPITHELIUM DEVELOPMENT | 14 | 125 | 2.22e-06 | 8.567e-05 |
120 | AGING | 21 | 264 | 2.228e-06 | 8.567e-05 |
121 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 62 | 1381 | 2.202e-06 | 8.567e-05 |
122 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 16 | 162 | 2.289e-06 | 8.729e-05 |
123 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 52 | 1087 | 2.634e-06 | 9.966e-05 |
124 | EMBRYONIC ORGAN DEVELOPMENT | 27 | 406 | 2.682e-06 | 0.0001006 |
125 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 27 | 408 | 2.941e-06 | 0.0001095 |
126 | CARTILAGE DEVELOPMENT | 15 | 147 | 3.151e-06 | 0.0001164 |
127 | RESPONSE TO WOUNDING | 33 | 563 | 3.378e-06 | 0.0001238 |
128 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 16 | 167 | 3.41e-06 | 0.000124 |
129 | REGULATION OF CELL CYCLE PHASE TRANSITION | 23 | 321 | 4.357e-06 | 0.0001572 |
130 | GLAND DEVELOPMENT | 26 | 395 | 4.94e-06 | 0.0001755 |
131 | EPITHELIAL CELL DIFFERENTIATION | 30 | 495 | 4.918e-06 | 0.0001755 |
132 | HAIR CYCLE | 11 | 83 | 5.298e-06 | 0.0001854 |
133 | MOLTING CYCLE | 11 | 83 | 5.298e-06 | 0.0001854 |
134 | STRIATED MUSCLE CELL DIFFERENTIATION | 16 | 173 | 5.389e-06 | 0.0001871 |
135 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 30 | 498 | 5.54e-06 | 0.000191 |
136 | EYE DEVELOPMENT | 23 | 326 | 5.628e-06 | 0.0001925 |
137 | CELL CYCLE CHECKPOINT | 17 | 194 | 5.719e-06 | 0.0001942 |
138 | REGULATION OF CHROMOSOME SEGREGATION | 11 | 85 | 6.703e-06 | 0.000225 |
139 | SISTER CHROMATID SEGREGATION | 16 | 176 | 6.721e-06 | 0.000225 |
140 | SKELETAL SYSTEM DEVELOPMENT | 28 | 455 | 7.672e-06 | 0.0002532 |
141 | RESPONSE TO TOXIC SUBSTANCE | 19 | 241 | 7.673e-06 | 0.0002532 |
142 | RESPONSE TO EXTERNAL STIMULUS | 74 | 1821 | 7.962e-06 | 0.0002609 |
143 | NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 17 | 199 | 8.033e-06 | 0.0002614 |
144 | POSITIVE REGULATION OF KINASE ACTIVITY | 29 | 482 | 8.132e-06 | 0.0002628 |
145 | CELL CYCLE | 58 | 1316 | 8.441e-06 | 0.0002709 |
146 | PATTERNING OF BLOOD VESSELS | 7 | 32 | 9.651e-06 | 0.0003076 |
147 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 64 | 1517 | 1.119e-05 | 0.0003541 |
148 | MESONEPHROS DEVELOPMENT | 11 | 90 | 1.172e-05 | 0.0003684 |
149 | NEURON RECOGNITION | 7 | 33 | 1.199e-05 | 0.0003746 |
150 | MITOTIC CELL CYCLE | 39 | 766 | 1.25e-05 | 0.0003877 |
151 | TELENCEPHALON DEVELOPMENT | 18 | 228 | 1.302e-05 | 0.0004012 |
152 | NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 14 | 146 | 1.372e-05 | 0.00042 |
153 | REGULATION OF CELLULAR LOCALIZATION | 56 | 1277 | 1.413e-05 | 0.0004297 |
154 | MUSCLE TISSUE DEVELOPMENT | 20 | 275 | 1.47e-05 | 0.0004412 |
155 | POSITIVE REGULATION OF LOCOMOTION | 26 | 420 | 1.461e-05 | 0.0004412 |
156 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 44 | 917 | 1.504e-05 | 0.0004485 |
157 | REGULATION OF GROWTH | 34 | 633 | 1.539e-05 | 0.0004532 |
158 | NEURON MIGRATION | 12 | 110 | 1.538e-05 | 0.0004532 |
159 | PEPTIDYL SERINE MODIFICATION | 14 | 148 | 1.602e-05 | 0.0004689 |
160 | REGULATION OF CELL PROJECTION ORGANIZATION | 31 | 558 | 1.923e-05 | 0.0005593 |
161 | REGULATION OF TRANSPORT | 72 | 1804 | 1.969e-05 | 0.0005691 |
162 | CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 5 | 15 | 2.058e-05 | 0.0005911 |
163 | NEGATIVE REGULATION OF CELL CYCLE PROCESS | 17 | 214 | 2.081e-05 | 0.000594 |
164 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 25 | 404 | 2.143e-05 | 0.0006052 |
165 | DEVELOPMENTAL MATURATION | 16 | 193 | 2.146e-05 | 0.0006052 |
166 | REGULATION OF CELL CELL ADHESION | 24 | 380 | 2.247e-05 | 0.0006298 |
167 | REGULATION OF PHOSPHOLIPASE ACTIVITY | 9 | 64 | 2.344e-05 | 0.0006493 |
168 | PALLIUM DEVELOPMENT | 14 | 153 | 2.334e-05 | 0.0006493 |
169 | NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 12 | 115 | 2.416e-05 | 0.0006653 |
170 | SINGLE ORGANISM CELL ADHESION | 27 | 459 | 2.479e-05 | 0.0006767 |
171 | DEVELOPMENTAL GROWTH | 22 | 333 | 2.487e-05 | 0.0006767 |
172 | EMBRYONIC MORPHOGENESIS | 30 | 539 | 2.53e-05 | 0.0006844 |
173 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 11 | 98 | 2.65e-05 | 0.0007128 |
174 | IN UTERO EMBRYONIC DEVELOPMENT | 21 | 311 | 2.75e-05 | 0.0007312 |
175 | RESPONSE TO OXYGEN LEVELS | 21 | 311 | 2.75e-05 | 0.0007312 |
176 | RESPONSE TO ALKALOID | 13 | 137 | 3.098e-05 | 0.0008189 |
177 | REGULATION OF SISTER CHROMATID SEGREGATION | 9 | 67 | 3.412e-05 | 0.000897 |
178 | REGULATION OF MITOTIC CELL CYCLE | 27 | 468 | 3.472e-05 | 0.0009076 |
179 | NEGATIVE REGULATION OF CELL ADHESION | 17 | 223 | 3.524e-05 | 0.0009161 |
180 | REGULATION OF CELL GROWTH | 24 | 391 | 3.556e-05 | 0.0009192 |
181 | MITOTIC CELL CYCLE CHECKPOINT | 13 | 139 | 3.61e-05 | 0.0009281 |
182 | TISSUE MIGRATION | 10 | 84 | 3.68e-05 | 0.0009306 |
183 | CYTOKINESIS | 10 | 84 | 3.68e-05 | 0.0009306 |
184 | POSITIVE REGULATION OF OSSIFICATION | 10 | 84 | 3.68e-05 | 0.0009306 |
185 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 13 | 140 | 3.893e-05 | 0.0009792 |
186 | CELL CELL ADHESION | 32 | 608 | 4.059e-05 | 0.001015 |
187 | REGULATION OF CALCIUM ION IMPORT | 11 | 103 | 4.231e-05 | 0.001052 |
188 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 57 | 1360 | 4.249e-05 | 0.001052 |
189 | NUCLEAR CHROMOSOME SEGREGATION | 17 | 228 | 4.662e-05 | 0.001148 |
190 | MORPHOGENESIS OF A POLARIZED EPITHELIUM | 6 | 28 | 4.827e-05 | 0.001182 |
191 | CELL JUNCTION ORGANIZATION | 15 | 185 | 4.988e-05 | 0.001215 |
192 | RESPONSE TO INORGANIC SUBSTANCE | 27 | 479 | 5.168e-05 | 0.001252 |
193 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 19 | 278 | 5.591e-05 | 0.001348 |
194 | CELL CYCLE PHASE TRANSITION | 18 | 255 | 5.759e-05 | 0.001381 |
195 | EPIDERMIS MORPHOGENESIS | 6 | 29 | 5.962e-05 | 0.001423 |
196 | RESPONSE TO ESTRADIOL | 13 | 146 | 6.032e-05 | 0.001425 |
197 | REGULATION OF SEQUESTERING OF CALCIUM ION | 11 | 107 | 6.024e-05 | 0.001425 |
198 | REGULATION OF AXONOGENESIS | 14 | 168 | 6.566e-05 | 0.001533 |
199 | MUCOPOLYSACCHARIDE METABOLIC PROCESS | 11 | 108 | 6.562e-05 | 0.001533 |
200 | NEGATIVE REGULATION OF CELL COMMUNICATION | 51 | 1192 | 6.591e-05 | 0.001533 |
201 | RESPONSE TO LIPID | 41 | 888 | 7.003e-05 | 0.001613 |
202 | MUSCLE CELL DEVELOPMENT | 12 | 128 | 6.993e-05 | 0.001613 |
203 | OSTEOCLAST DIFFERENTIATION | 6 | 30 | 7.301e-05 | 0.001673 |
204 | GROWTH | 24 | 410 | 7.5e-05 | 0.001711 |
205 | REGULATION OF HYDROLASE ACTIVITY | 55 | 1327 | 7.855e-05 | 0.001783 |
206 | NEGATIVE REGULATION OF NEURON DEATH | 14 | 171 | 7.954e-05 | 0.001797 |
207 | REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 10 | 92 | 8.082e-05 | 0.001817 |
208 | MITOTIC NUCLEAR DIVISION | 22 | 361 | 8.296e-05 | 0.001856 |
209 | SISTER CHROMATID COHESION | 11 | 111 | 8.433e-05 | 0.00187 |
210 | REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 9 | 75 | 8.441e-05 | 0.00187 |
211 | PROTEIN LOCALIZATION TO CELL PERIPHERY | 13 | 151 | 8.531e-05 | 0.001881 |
212 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 20 | 312 | 8.739e-05 | 0.001918 |
213 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 11 | 112 | 9.15e-05 | 0.001999 |
214 | RESPONSE TO VITAMIN A | 5 | 20 | 9.606e-05 | 0.002079 |
215 | AXONAL FASCICULATION | 5 | 20 | 9.606e-05 | 0.002079 |
216 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 8 | 60 | 9.827e-05 | 0.002117 |
217 | SPROUTING ANGIOGENESIS | 7 | 45 | 9.901e-05 | 0.002123 |
218 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 12 | 133 | 0.0001013 | 0.002163 |
219 | RESPIRATORY SYSTEM DEVELOPMENT | 15 | 197 | 0.0001018 | 0.002164 |
220 | CELL CYCLE ARREST | 13 | 154 | 0.0001042 | 0.002205 |
221 | REGULATION OF EMBRYONIC DEVELOPMENT | 11 | 114 | 0.0001074 | 0.002262 |
222 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 8 | 61 | 0.0001107 | 0.002321 |
223 | REGULATION OF CYTOSKELETON ORGANIZATION | 27 | 502 | 0.0001132 | 0.002361 |
224 | RENAL TUBULE DEVELOPMENT | 9 | 78 | 0.0001149 | 0.002387 |
225 | CELL DEATH | 44 | 1001 | 0.0001171 | 0.002421 |
226 | GLAND MORPHOGENESIS | 10 | 97 | 0.0001265 | 0.002605 |
227 | CHROMOSOME SEGREGATION | 18 | 272 | 0.0001311 | 0.002675 |
228 | REGULATION OF CELL DIVISION | 18 | 272 | 0.0001311 | 0.002675 |
229 | CELL CELL SIGNALING | 36 | 767 | 0.0001412 | 0.002869 |
230 | TRACHEA MORPHOGENESIS | 4 | 12 | 0.0001472 | 0.002977 |
231 | DIGESTIVE TRACT MORPHOGENESIS | 7 | 48 | 0.0001508 | 0.003025 |
232 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 35 | 740 | 0.0001508 | 0.003025 |
233 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 34 | 0.0001523 | 0.003041 |
234 | CELLULAR MACROMOLECULE LOCALIZATION | 51 | 1234 | 0.0001553 | 0.003088 |
235 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 28 | 541 | 0.0001618 | 0.00319 |
236 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 28 | 541 | 0.0001618 | 0.00319 |
237 | MUSCLE ORGAN DEVELOPMENT | 18 | 277 | 0.0001645 | 0.003229 |
238 | KIDNEY MORPHOGENESIS | 9 | 82 | 0.0001695 | 0.003314 |
239 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 14 | 184 | 0.0001733 | 0.003374 |
240 | REGULATION OF ORGANELLE ORGANIZATION | 49 | 1178 | 0.0001807 | 0.003503 |
241 | REGULATION OF LIPASE ACTIVITY | 9 | 83 | 0.0001861 | 0.003593 |
242 | PEPTIDYL TYROSINE MODIFICATION | 14 | 186 | 0.000194 | 0.003731 |
243 | PROTEIN LOCALIZATION | 68 | 1805 | 0.0001951 | 0.003736 |
244 | CELL SUBSTRATE ADHESION | 13 | 164 | 0.0001959 | 0.003736 |
245 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 25 | 465 | 0.0002026 | 0.003848 |
246 | MUSCLE SYSTEM PROCESS | 18 | 282 | 0.0002052 | 0.003881 |
247 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 10 | 103 | 0.0002085 | 0.003896 |
248 | PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 4 | 13 | 0.0002085 | 0.003896 |
249 | GANGLION DEVELOPMENT | 4 | 13 | 0.0002085 | 0.003896 |
250 | REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 6 | 36 | 0.0002116 | 0.003939 |
251 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 8 | 67 | 0.0002159 | 0.004003 |
252 | SKIN DEVELOPMENT | 15 | 211 | 0.0002172 | 0.004011 |
253 | AMINOGLYCAN METABOLIC PROCESS | 13 | 166 | 0.0002209 | 0.004062 |
254 | IMMUNE SYSTEM PROCESS | 73 | 1984 | 0.0002262 | 0.004112 |
255 | CARDIAC CHAMBER MORPHOGENESIS | 10 | 104 | 0.0002257 | 0.004112 |
256 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 10 | 104 | 0.0002257 | 0.004112 |
257 | HEART MORPHOGENESIS | 15 | 212 | 0.0002286 | 0.00414 |
258 | RESPONSE TO ALCOHOL | 21 | 362 | 0.0002354 | 0.004245 |
259 | POSITIVE REGULATION OF MAPK CASCADE | 25 | 470 | 0.0002383 | 0.004249 |
260 | WOUND HEALING | 25 | 470 | 0.0002383 | 0.004249 |
261 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 25 | 470 | 0.0002383 | 0.004249 |
262 | MESENCHYME DEVELOPMENT | 14 | 190 | 0.0002419 | 0.00428 |
263 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 14 | 190 | 0.0002419 | 0.00428 |
264 | BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 5 | 24 | 0.000243 | 0.004283 |
265 | CEREBRAL CORTEX DEVELOPMENT | 10 | 105 | 0.0002442 | 0.004287 |
266 | POSITIVE REGULATION OF GROWTH | 16 | 238 | 0.0002559 | 0.004477 |
267 | POSITIVE REGULATION OF AXONOGENESIS | 8 | 69 | 0.0002653 | 0.004589 |
268 | RESPONSE TO ACTIVITY | 8 | 69 | 0.0002653 | 0.004589 |
269 | SYNAPSE ASSEMBLY | 8 | 69 | 0.0002653 | 0.004589 |
270 | TISSUE REMODELING | 9 | 87 | 0.0002665 | 0.004593 |
271 | REGULATION OF NEURON APOPTOTIC PROCESS | 14 | 192 | 0.0002695 | 0.004627 |
272 | DIGESTIVE SYSTEM DEVELOPMENT | 12 | 148 | 0.0002777 | 0.00475 |
273 | AMINOGLYCAN BIOSYNTHETIC PROCESS | 10 | 107 | 0.0002849 | 0.004837 |
274 | MESONEPHRIC TUBULE MORPHOGENESIS | 7 | 53 | 0.0002844 | 0.004837 |
275 | HISTONE PHOSPHORYLATION | 5 | 25 | 0.0002977 | 0.005019 |
276 | REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 5 | 25 | 0.0002977 | 0.005019 |
277 | SYNAPTIC SIGNALING | 23 | 424 | 0.0003179 | 0.005339 |
278 | TUBE FORMATION | 11 | 129 | 0.0003206 | 0.005346 |
279 | CELL JUNCTION ASSEMBLY | 11 | 129 | 0.0003206 | 0.005346 |
280 | REGULATION OF PHOSPHOLIPASE C ACTIVITY | 6 | 39 | 0.0003333 | 0.005539 |
281 | REGULATION OF CELL MATRIX ADHESION | 9 | 90 | 0.0003442 | 0.005679 |
282 | ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 9 | 90 | 0.0003442 | 0.005679 |
283 | FORMATION OF PRIMARY GERM LAYER | 10 | 110 | 0.0003564 | 0.00586 |
284 | EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 55 | 0.0003591 | 0.005884 |
285 | NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT | 5 | 26 | 0.0003613 | 0.005898 |
286 | CELL MATURATION | 11 | 131 | 0.0003661 | 0.005956 |
287 | CELLULAR RESPONSE TO ACID CHEMICAL | 13 | 175 | 0.0003695 | 0.005969 |
288 | GLIOGENESIS | 13 | 175 | 0.0003695 | 0.005969 |
289 | MITOTIC SISTER CHROMATID SEGREGATION | 9 | 91 | 0.0003739 | 0.00602 |
290 | ENDODERMAL CELL DIFFERENTIATION | 6 | 40 | 0.0003842 | 0.006101 |
291 | ECTODERMAL PLACODE DEVELOPMENT | 4 | 15 | 0.0003829 | 0.006101 |
292 | ECTODERMAL PLACODE MORPHOGENESIS | 4 | 15 | 0.0003829 | 0.006101 |
293 | ECTODERMAL PLACODE FORMATION | 4 | 15 | 0.0003829 | 0.006101 |
294 | POSITIVE REGULATION OF CELL CYCLE PROCESS | 16 | 247 | 0.0003872 | 0.006128 |
295 | POSITIVE REGULATION OF CELL ADHESION | 21 | 376 | 0.0003906 | 0.006161 |
296 | REGULATION OF MAPK CASCADE | 31 | 660 | 0.0004021 | 0.006236 |
297 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 12 | 154 | 0.0003997 | 0.006236 |
298 | AMEBOIDAL TYPE CELL MIGRATION | 12 | 154 | 0.0003997 | 0.006236 |
299 | RESPONSE TO DRUG | 23 | 431 | 4e-04 | 0.006236 |
300 | POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 7 | 56 | 0.0004019 | 0.006236 |
301 | GASTRULATION | 12 | 155 | 0.0004239 | 0.006553 |
302 | REGULATION OF ION HOMEOSTASIS | 14 | 201 | 0.0004293 | 0.006593 |
303 | RESPONSE TO OXIDATIVE STRESS | 20 | 352 | 0.0004293 | 0.006593 |
304 | NEPHRON EPITHELIUM DEVELOPMENT | 9 | 93 | 0.0004396 | 0.006726 |
305 | REGULATION OF SYNAPSE ORGANIZATION | 10 | 113 | 0.0004423 | 0.006726 |
306 | REGULATION OF STEM CELL DIFFERENTIATION | 10 | 113 | 0.0004423 | 0.006726 |
307 | MESENCHYMAL CELL DIFFERENTIATION | 11 | 134 | 0.0004444 | 0.006736 |
308 | NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 12 | 156 | 0.0004493 | 0.006788 |
309 | NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 11 | 135 | 0.0004735 | 0.007094 |
310 | PLASMA MEMBRANE ORGANIZATION | 14 | 203 | 0.0004742 | 0.007094 |
311 | CELL FATE COMMITMENT | 15 | 227 | 0.0004739 | 0.007094 |
312 | ACTION POTENTIAL | 9 | 94 | 0.0004759 | 0.007098 |
313 | REGULATION OF NEURON DEATH | 16 | 252 | 0.0004825 | 0.007173 |
314 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 18 | 303 | 0.0004874 | 0.007223 |
315 | MICROTUBULE BASED PROCESS | 26 | 522 | 0.0004923 | 0.007272 |
316 | NEGATIVE REGULATION OF WOUND HEALING | 7 | 58 | 0.0004998 | 0.007359 |
317 | NEPHRON DEVELOPMENT | 10 | 115 | 0.0005086 | 0.007466 |
318 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 15 | 229 | 0.0005194 | 0.007549 |
319 | RESPONSE TO COPPER ION | 5 | 28 | 0.0005186 | 0.007549 |
320 | NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 5 | 28 | 0.0005186 | 0.007549 |
321 | EMBRYONIC ORGAN MORPHOGENESIS | 17 | 279 | 0.0005208 | 0.007549 |
322 | RESPONSE TO STEROID HORMONE | 25 | 497 | 0.0005448 | 0.007824 |
323 | REGULATION OF RESPONSE TO WOUNDING | 22 | 413 | 0.0005441 | 0.007824 |
324 | POSITIVE REGULATION OF CELL CYCLE | 19 | 332 | 0.0005431 | 0.007824 |
325 | REGULATION OF GTPASE ACTIVITY | 31 | 673 | 0.0005571 | 0.007976 |
326 | ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 8 | 77 | 0.0005637 | 0.008027 |
327 | REGULATION OF PROTEIN LOCALIZATION | 40 | 950 | 0.0005641 | 0.008027 |
328 | NEGATIVE REGULATION OF CELL CELL ADHESION | 11 | 138 | 0.0005703 | 0.008091 |
329 | CEREBRAL CORTEX CELL MIGRATION | 6 | 43 | 0.0005737 | 0.008114 |
330 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 44 | 1079 | 0.0005869 | 0.008275 |
331 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 15 | 232 | 0.0005947 | 0.00835 |
332 | CELLULAR RESPONSE TO OXIDATIVE STRESS | 13 | 184 | 0.0005958 | 0.00835 |
333 | RESPONSE TO NITROGEN COMPOUND | 37 | 859 | 0.0005976 | 0.008351 |
334 | REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 9 | 97 | 0.0005998 | 0.008356 |
335 | REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 14 | 208 | 0.000604 | 0.00839 |
336 | NEGATIVE REGULATION OF CELL DIVISION | 7 | 60 | 0.0006157 | 0.008501 |
337 | REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 5 | 29 | 0.0006142 | 0.008501 |
338 | MUSCLE CONTRACTION | 15 | 233 | 0.0006217 | 0.008559 |
339 | REGULATION OF CALCIUM ION TRANSPORT | 14 | 209 | 0.0006333 | 0.008693 |
340 | PATTERN SPECIFICATION PROCESS | 22 | 418 | 0.0006385 | 0.008738 |
341 | STRIATED MUSCLE CONTRACTION | 9 | 99 | 0.0006961 | 0.009478 |
342 | RESPONSE TO ABIOTIC STIMULUS | 42 | 1024 | 0.0006967 | 0.009478 |
343 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 37 | 867 | 0.0007084 | 0.009609 |
344 | SMOOTH MUSCLE CONTRACTION | 6 | 45 | 0.0007357 | 0.009951 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PROTEIN KINASE ACTIVITY | 49 | 640 | 1.353e-12 | 1.257e-09 |
2 | ENZYME BINDING | 88 | 1737 | 2.557e-11 | 1.188e-08 |
3 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 37 | 445 | 8.525e-11 | 2.64e-08 |
4 | KINASE ACTIVITY | 52 | 842 | 7.475e-10 | 1.736e-07 |
5 | RIBONUCLEOTIDE BINDING | 85 | 1860 | 8.98e-09 | 1.669e-06 |
6 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 53 | 992 | 6.92e-08 | 1.071e-05 |
7 | PROTEIN COMPLEX BINDING | 50 | 935 | 1.628e-07 | 2.161e-05 |
8 | CYTOSKELETAL PROTEIN BINDING | 44 | 819 | 8.318e-07 | 8.173e-05 |
9 | KINASE BINDING | 36 | 606 | 8.798e-07 | 8.173e-05 |
10 | MACROMOLECULAR COMPLEX BINDING | 64 | 1399 | 7.819e-07 | 8.173e-05 |
11 | RECEPTOR BINDING | 65 | 1476 | 2.329e-06 | 0.0001967 |
12 | PROTEIN DOMAIN SPECIFIC BINDING | 35 | 624 | 4.523e-06 | 0.0003502 |
13 | ADENYL NUCLEOTIDE BINDING | 65 | 1514 | 5.392e-06 | 0.0003853 |
14 | HISTONE DEACETYLASE BINDING | 12 | 105 | 9.524e-06 | 0.000632 |
15 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 22 | 315 | 1.052e-05 | 0.0006517 |
16 | SH3 DOMAIN BINDING | 12 | 116 | 2.637e-05 | 0.001531 |
17 | CADHERIN BINDING | 6 | 28 | 4.827e-05 | 0.002638 |
18 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 31 | 588 | 5.184e-05 | 0.002675 |
19 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 32 | 629 | 7.709e-05 | 0.003769 |
20 | ION CHANNEL BINDING | 11 | 111 | 8.433e-05 | 0.003917 |
21 | ANKYRIN BINDING | 5 | 20 | 9.606e-05 | 0.004249 |
22 | MOLECULAR FUNCTION REGULATOR | 55 | 1353 | 0.00013 | 0.00549 |
23 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 9 | 81 | 0.0001542 | 0.006227 |
24 | GROWTH FACTOR BINDING | 11 | 123 | 0.0002115 | 0.008189 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL JUNCTION | 69 | 1151 | 3.478e-12 | 2.031e-09 |
2 | ANCHORING JUNCTION | 39 | 489 | 8.961e-11 | 2.616e-08 |
3 | CYTOSKELETON | 92 | 1967 | 5.79e-10 | 1.127e-07 |
4 | CELL SUBSTRATE JUNCTION | 33 | 398 | 9.89e-10 | 1.444e-07 |
5 | CHROMOSOME CENTROMERIC REGION | 17 | 174 | 1.29e-06 | 0.0001507 |
6 | CYTOSKELETAL PART | 64 | 1436 | 1.891e-06 | 0.0001578 |
7 | CELL SURFACE | 41 | 757 | 1.636e-06 | 0.0001578 |
8 | CELL CELL JUNCTION | 26 | 383 | 2.825e-06 | 0.0002062 |
9 | PERINUCLEAR REGION OF CYTOPLASM | 36 | 642 | 3.316e-06 | 0.0002152 |
10 | CELL PROJECTION | 74 | 1786 | 4.008e-06 | 0.0002341 |
11 | CONTRACTILE FIBER | 18 | 211 | 4.456e-06 | 0.0002366 |
12 | NEURON PROJECTION | 46 | 942 | 6.075e-06 | 0.0002956 |
13 | I BAND | 13 | 121 | 8.091e-06 | 0.0003375 |
14 | MICROTUBULE CYTOSKELETON | 50 | 1068 | 7.52e-06 | 0.0003375 |
15 | CELL LEADING EDGE | 23 | 350 | 1.778e-05 | 0.0006923 |
16 | LAMELLIPODIUM | 15 | 172 | 2.131e-05 | 0.000778 |
17 | AXON | 25 | 418 | 3.763e-05 | 0.001221 |
18 | MEMBRANE REGION | 50 | 1134 | 3.658e-05 | 0.001221 |
19 | CONDENSED NUCLEAR CHROMOSOME CENTROMERIC REGION | 5 | 18 | 5.527e-05 | 0.001699 |
20 | GOLGI APPARATUS | 59 | 1445 | 6.442e-05 | 0.001881 |
21 | NEURON PART | 53 | 1265 | 8.107e-05 | 0.002255 |
22 | PLASMA MEMBRANE REGION | 42 | 929 | 9.108e-05 | 0.002418 |
23 | EXTRACELLULAR MATRIX | 24 | 426 | 0.0001347 | 0.003421 |
24 | CONDENSED CHROMOSOME OUTER KINETOCHORE | 4 | 12 | 0.0001472 | 0.003581 |
25 | GOLGI APPARATUS PART | 40 | 893 | 0.0001627 | 0.003678 |
26 | MICROTUBULE | 23 | 405 | 0.0001646 | 0.003678 |
27 | KINETOCHORE | 11 | 120 | 0.0001701 | 0.003678 |
28 | LATERAL PLASMA MEMBRANE | 7 | 50 | 0.0001962 | 0.004093 |
29 | SYNAPSE | 35 | 754 | 0.0002153 | 0.004335 |
30 | SUPRAMOLECULAR FIBER | 32 | 670 | 0.0002427 | 0.004724 |
31 | MEMBRANE MICRODOMAIN | 18 | 288 | 0.0002654 | 0.004901 |
32 | CELL PROJECTION PART | 41 | 946 | 0.0002685 | 0.004901 |
33 | APICAL JUNCTION COMPLEX | 11 | 128 | 0.0002997 | 0.005303 |
34 | CELL CELL ADHERENS JUNCTION | 7 | 54 | 0.00032 | 0.005497 |
35 | RECEPTOR COMPLEX | 19 | 327 | 0.0004512 | 0.007529 |
36 | CHROMOSOMAL REGION | 19 | 330 | 0.0005046 | 0.008185 |
37 | ACTIN CYTOSKELETON | 23 | 444 | 0.000603 | 0.009267 |
38 | APICAL PART OF CELL | 20 | 361 | 0.0005902 | 0.009267 |
39 | SOMATODENDRITIC COMPARTMENT | 30 | 650 | 0.0006599 | 0.009882 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Cell_cycle_hsa04110 | 21 | 124 | 2.499e-12 | 1.3e-10 | |
2 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 20 | 139 | 1.779e-10 | 4.625e-09 | |
3 | Ras_signaling_pathway_hsa04014 | 25 | 232 | 5.457e-10 | 9.459e-09 | |
4 | HIF_1_signaling_pathway_hsa04066 | 15 | 100 | 1.923e-08 | 2.5e-07 | |
5 | Focal_adhesion_hsa04510 | 20 | 199 | 9.465e-08 | 9.844e-07 | |
6 | PI3K_Akt_signaling_pathway_hsa04151 | 26 | 352 | 5.848e-07 | 5.068e-06 | |
7 | FoxO_signaling_pathway_hsa04068 | 15 | 132 | 8.02e-07 | 5.647e-06 | |
8 | Regulation_of_actin_cytoskeleton_hsa04810 | 19 | 208 | 8.687e-07 | 5.647e-06 | |
9 | Hippo_signaling_pathway_hsa04390 | 16 | 154 | 1.167e-06 | 6.745e-06 | |
10 | Cellular_senescence_hsa04218 | 16 | 160 | 1.942e-06 | 1.01e-05 | |
11 | MAPK_signaling_pathway_hsa04010 | 22 | 295 | 3.695e-06 | 1.747e-05 | |
12 | Wnt_signaling_pathway_hsa04310 | 14 | 146 | 1.372e-05 | 5.945e-05 | |
13 | TGF_beta_signaling_pathway_hsa04350 | 10 | 84 | 3.68e-05 | 0.0001472 | |
14 | Oocyte_meiosis_hsa04114 | 12 | 124 | 5.123e-05 | 0.0001903 | |
15 | Sphingolipid_signaling_pathway_hsa04071 | 11 | 118 | 0.0001464 | 0.0005076 | |
16 | Rap1_signaling_pathway_hsa04015 | 15 | 206 | 0.0001672 | 0.0005433 | |
17 | ErbB_signaling_pathway_hsa04012 | 9 | 85 | 0.0002233 | 0.0006831 | |
18 | Apoptosis_hsa04210 | 11 | 138 | 0.0005703 | 0.001648 | |
19 | ECM_receptor_interaction_hsa04512 | 8 | 82 | 0.0008591 | 0.002351 | |
20 | cAMP_signaling_pathway_hsa04024 | 13 | 198 | 0.001175 | 0.003054 | |
21 | Gap_junction_hsa04540 | 8 | 88 | 0.001365 | 0.003381 | |
22 | Adherens_junction_hsa04520 | 7 | 72 | 0.00183 | 0.004324 | |
23 | Phospholipase_D_signaling_pathway_hsa04072 | 10 | 146 | 0.003106 | 0.007022 | |
24 | mTOR_signaling_pathway_hsa04150 | 10 | 151 | 0.003951 | 0.00856 | |
25 | TNF_signaling_pathway_hsa04668 | 8 | 108 | 0.004914 | 0.01022 | |
26 | Hedgehog_signaling_pathway_hsa04340 | 5 | 47 | 0.005544 | 0.01109 | |
27 | cGMP_PKG_signaling_pathway_hsa04022 | 10 | 163 | 0.006725 | 0.01295 | |
28 | Cell_adhesion_molecules_.CAMs._hsa04514 | 9 | 145 | 0.009196 | 0.01708 | |
29 | Autophagy_animal_hsa04140 | 8 | 128 | 0.01316 | 0.02359 | |
30 | Calcium_signaling_pathway_hsa04020 | 10 | 182 | 0.01395 | 0.02396 | |
31 | VEGF_signaling_pathway_hsa04370 | 5 | 59 | 0.01429 | 0.02396 | |
32 | Ferroptosis_hsa04216 | 4 | 40 | 0.01589 | 0.02581 | |
33 | Apelin_signaling_pathway_hsa04371 | 8 | 137 | 0.01909 | 0.03008 | |
34 | Mitophagy_animal_hsa04137 | 5 | 65 | 0.02096 | 0.03205 | |
35 | NF_kappa_B_signaling_pathway_hsa04064 | 6 | 95 | 0.02856 | 0.04243 | |
36 | Hippo_signaling_pathway_multiple_species_hsa04392 | 3 | 29 | 0.03281 | 0.04739 | |
37 | Endocytosis_hsa04144 | 11 | 244 | 0.03732 | 0.05245 | |
38 | Tight_junction_hsa04530 | 8 | 170 | 0.05677 | 0.07768 | |
39 | Apoptosis_multiple_species_hsa04215 | 2 | 33 | 0.1915 | 0.2554 | |
40 | Jak_STAT_signaling_pathway_hsa04630 | 6 | 162 | 0.2036 | 0.2647 | |
41 | p53_signaling_pathway_hsa04115 | 3 | 68 | 0.2299 | 0.2915 | |
42 | ABC_transporters_hsa02010 | 2 | 45 | 0.2999 | 0.3713 | |
43 | Phagosome_hsa04145 | 5 | 152 | 0.312 | 0.3774 | |
44 | Notch_signaling_pathway_hsa04330 | 2 | 48 | 0.3269 | 0.3863 | |
45 | AMPK_signaling_pathway_hsa04152 | 4 | 121 | 0.3405 | 0.3935 | |
46 | Phosphatidylinositol_signaling_system_hsa04070 | 3 | 99 | 0.4346 | 0.4913 | |
47 | Cytokine_cytokine_receptor_interaction_hsa04060 | 7 | 270 | 0.4869 | 0.5387 | |
48 | Peroxisome_hsa04146 | 2 | 83 | 0.6036 | 0.6405 | |
49 | Necroptosis_hsa04217 | 3 | 164 | 0.7657 | 0.7964 | |
50 | Neuroactive_ligand_receptor_interaction_hsa04080 | 3 | 278 | 0.9671 | 0.9671 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | HCG11 |
hsa-miR-10b-3p;hsa-miR-1180-3p;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-221-3p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-455-5p;hsa-miR-532-3p | 12 | ETS1 | Sponge network | -0.781 | 0 | -0.888 | 0 | 0.78 |
2 | SNHG1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 11 | CCNA2 | Sponge network | 2.013 | 0 | 3.368 | 0 | 0.678 |
3 | TMPO-AS1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p | 12 | CCNA2 | Sponge network | 2.165 | 0 | 3.368 | 0 | 0.67 |
4 | RP5-1074L1.4 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-374b-5p;hsa-miR-486-5p | 14 | CCNA2 | Sponge network | 2.302 | 0 | 3.368 | 0 | 0.658 |
5 | AP001469.9 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 13 | CCNA2 | Sponge network | 2.428 | 0 | 3.368 | 0 | 0.619 |
6 | DHRS4-AS1 |
hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-421;hsa-miR-500a-5p;hsa-miR-501-5p | 10 | ARHGAP5 | Sponge network | -0.646 | 0.01829 | -0.391 | 8.0E-5 | 0.615 |
7 | MAPKAPK5-AS1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 1.411 | 0 | 3.368 | 0 | 0.604 |
8 | PXN-AS1 | hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p | 11 | CCNA2 | Sponge network | 1.561 | 0 | 3.368 | 0 | 0.591 |
9 | RP11-498C9.15 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-374b-5p | 11 | CCNA2 | Sponge network | 1.487 | 0 | 3.368 | 0 | 0.589 |
10 | KB-1572G7.2 | hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-374b-5p;hsa-miR-486-5p | 12 | CCNA2 | Sponge network | 2.124 | 0 | 3.368 | 0 | 0.57 |
11 | DHRS4-AS1 |
hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-582-5p;hsa-miR-589-3p | 10 | PIK3R1 | Sponge network | -0.646 | 0.01829 | -0.892 | 0 | 0.557 |
12 | RP11-1246C19.1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p | 12 | CCNA2 | Sponge network | 2.721 | 0 | 3.368 | 0 | 0.556 |
13 | GUSBP11 | hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-374b-5p;hsa-miR-486-5p | 12 | CCNA2 | Sponge network | 2.066 | 0 | 3.368 | 0 | 0.54 |
14 | AC074117.10 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 1.254 | 0 | 3.368 | 0 | 0.537 |
15 | TMCC1-AS1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 2.298 | 0 | 3.368 | 0 | 0.533 |
16 | RP4-717I23.3 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 11 | CCNA2 | Sponge network | 1.867 | 0 | 3.368 | 0 | 0.531 |
17 | RP11-434D9.1 | hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-409-3p;hsa-miR-629-3p | 13 | PIK3R1 | Sponge network | -2.913 | 0 | -0.892 | 0 | 0.525 |
18 | PRKAR2A-AS1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p | 11 | CCNA2 | Sponge network | 2.366 | 0 | 3.368 | 0 | 0.52 |
19 | LINC00261 |
hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-15b-5p;hsa-miR-188-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-330-3p;hsa-miR-589-3p;hsa-miR-629-3p | 13 | PIK3R1 | Sponge network | -1.194 | 0 | -0.892 | 0 | 0.513 |
20 | RP11-111M22.4 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29b-1-5p;hsa-miR-374b-5p | 10 | CCNA2 | Sponge network | 3.722 | 0 | 3.368 | 0 | 0.509 |
21 | GAS5 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29c-3p;hsa-miR-374b-5p | 11 | CCNA2 | Sponge network | 1.966 | 0 | 3.368 | 0 | 0.506 |
22 | NPSR1-AS1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 13 | CCNA2 | Sponge network | 5.28 | 0 | 3.368 | 0 | 0.505 |
23 | CTD-2561J22.5 | hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 11 | CCNA2 | Sponge network | 2.129 | 0 | 3.368 | 0 | 0.495 |
24 | SNHG7 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 2.077 | 0 | 3.368 | 0 | 0.494 |
25 | RP11-513G11.3 | hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-93-5p | 10 | PIK3R1 | Sponge network | -2.342 | 5.0E-5 | -0.892 | 0 | 0.492 |
26 | CTC-338M12.4 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 1.926 | 0 | 3.368 | 0 | 0.491 |
27 | RP11-12A2.3 |
hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-188-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-93-5p | 14 | PIK3R1 | Sponge network | -4.779 | 0 | -0.892 | 0 | 0.489 |
28 | RP11-216L13.19 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 2.404 | 0 | 3.368 | 0 | 0.482 |
29 | RP11-328N19.1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p | 11 | CCNA2 | Sponge network | 7.657 | 0 | 3.368 | 0 | 0.48 |
30 | AC098820.3 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 1.898 | 0 | 3.368 | 0 | 0.475 |
31 | RAB30-AS1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 1.001 | 0 | 3.368 | 0 | 0.475 |
32 | AC005154.6 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 1.75 | 0 | 3.368 | 0 | 0.473 |
33 | LINC01018 |
hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-338-5p;hsa-miR-409-3p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-93-5p | 18 | PIK3R1 | Sponge network | -3.231 | 0 | -0.892 | 0 | 0.472 |
34 | HCG11 |
hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-501-3p;hsa-miR-93-5p | 11 | TGFBR2 | Sponge network | -0.781 | 0 | -0.523 | 3.0E-5 | 0.472 |
35 | RP11-727A23.5 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29c-3p;hsa-miR-486-5p | 12 | CCNA2 | Sponge network | 1.435 | 0 | 3.368 | 0 | 0.468 |
36 | RP5-1120P11.1 | hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 12 | CCNA2 | Sponge network | 3.942 | 0 | 3.368 | 0 | 0.465 |
37 | RP11-37B2.1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 1.504 | 0 | 3.368 | 0 | 0.459 |
38 | LINC01004 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-374b-5p | 10 | CCNA2 | Sponge network | 2.116 | 0 | 3.368 | 0 | 0.458 |
39 | HCG18 | hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 1.42 | 0 | 3.368 | 0 | 0.457 |
40 | TEX41 | hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 11 | CCNA2 | Sponge network | 3.293 | 0 | 3.368 | 0 | 0.452 |
41 | HOTTIP | hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 7.501 | 0 | 3.368 | 0 | 0.452 |
42 | RHPN1-AS1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 11 | CCNA2 | Sponge network | 1.895 | 0 | 3.368 | 0 | 0.451 |
43 | LDLRAD4-AS1 |
hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-589-3p;hsa-miR-93-5p | 13 | PIK3R1 | Sponge network | -3.366 | 0 | -0.892 | 0 | 0.45 |
44 | ERVK3-1 | hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-374b-5p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 1.328 | 0 | 3.368 | 0 | 0.448 |
45 | HOXA11-AS | hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 6.056 | 0 | 3.368 | 0 | 0.448 |
46 | AC005550.3 |
hsa-miR-15b-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-21-5p;hsa-miR-215-5p;hsa-miR-217;hsa-miR-222-3p;hsa-miR-92a-3p | 10 | FGF2 | Sponge network | -2.571 | 0.00132 | -1.086 | 0.00032 | 0.448 |
47 | AC159540.1 | hsa-let-7b-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-374b-5p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 2.112 | 0 | 3.368 | 0 | 0.442 |
48 | RP11-458D21.1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p | 12 | CCNA2 | Sponge network | 1.399 | 0 | 3.368 | 0 | 0.439 |
49 | AC062029.1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 1.067 | 0 | 3.368 | 0 | 0.435 |
50 | RP11-758M4.4 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p | 11 | CCNA2 | Sponge network | 3.598 | 0 | 3.368 | 0 | 0.433 |
51 | MAGI2-AS3 |
hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-454-3p;hsa-miR-92a-3p;hsa-miR-93-5p | 12 | TGFBR2 | Sponge network | -1.801 | 0 | -0.523 | 3.0E-5 | 0.428 |
52 | RP11-540A21.2 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 13 | CCNA2 | Sponge network | 1.758 | 0 | 3.368 | 0 | 0.425 |
53 | LINC00668 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 3.665 | 0 | 3.368 | 0 | 0.422 |
54 | PSMD5-AS1 | hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 1.538 | 0 | 3.368 | 0 | 0.42 |
55 | RP11-119D9.1 |
hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-188-5p;hsa-miR-200c-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p;hsa-miR-93-5p | 11 | PIK3R1 | Sponge network | -2.765 | 0 | -0.892 | 0 | 0.418 |
56 | RP11-166D19.1 |
hsa-miR-1180-3p;hsa-miR-148b-5p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-222-3p;hsa-miR-421;hsa-miR-532-3p;hsa-miR-590-5p;hsa-miR-940 | 10 | ETS1 | Sponge network | -0.244 | 0.28835 | -0.888 | 0 | 0.417 |
57 | MAGI2-AS3 |
hsa-miR-10b-3p;hsa-miR-1180-3p;hsa-miR-193a-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-455-5p;hsa-miR-501-5p;hsa-miR-532-3p;hsa-miR-660-5p;hsa-miR-769-5p;hsa-miR-940 | 13 | ETS1 | Sponge network | -1.801 | 0 | -0.888 | 0 | 0.413 |
58 | AC012146.7 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p | 11 | CCNA2 | Sponge network | 1.709 | 0 | 3.368 | 0 | 0.413 |
59 | CTBP1-AS2 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 11 | CCNA2 | Sponge network | 1.419 | 0 | 3.368 | 0 | 0.406 |
60 | CRNDE | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 11 | CCNA2 | Sponge network | 3.271 | 0 | 3.368 | 0 | 0.404 |
61 | RP11-290F5.1 | hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-493-5p | 13 | PIK3R1 | Sponge network | -1.679 | 5.0E-5 | -0.892 | 0 | 0.402 |
62 | GS1-124K5.11 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 1.5 | 0 | 3.368 | 0 | 0.402 |
63 | DNAJC3-AS1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-374b-5p | 11 | CCNA2 | Sponge network | 0.905 | 0 | 3.368 | 0 | 0.395 |
64 | KB-431C1.4 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 1.573 | 0 | 3.368 | 0 | 0.39 |
65 | DHRS4-AS1 |
hsa-miR-1180-3p;hsa-miR-148b-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-30d-3p;hsa-miR-421;hsa-miR-501-5p;hsa-miR-502-5p;hsa-miR-660-5p;hsa-miR-769-5p | 10 | ETS1 | Sponge network | -0.646 | 0.01829 | -0.888 | 0 | 0.384 |
66 | RP11-115J16.1 | hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-185-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-338-5p;hsa-miR-589-3p;hsa-miR-93-5p | 12 | PIK3R1 | Sponge network | -2.038 | 7.0E-5 | -0.892 | 0 | 0.382 |
67 | CTD-2228K2.7 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-374b-5p;hsa-miR-486-5p | 11 | CCNA2 | Sponge network | 2.28 | 0 | 3.368 | 0 | 0.379 |
68 | RP4-601P9.2 | hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-200c-3p;hsa-miR-21-3p;hsa-miR-21-5p;hsa-miR-217;hsa-miR-335-3p | 10 | FGF2 | Sponge network | -1.638 | 0.0053 | -1.086 | 0.00032 | 0.376 |
69 | AL133493.2 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 11 | CCNA2 | Sponge network | 2.464 | 0.00305 | 3.368 | 0 | 0.372 |
70 | LINC00238 | hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-188-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p | 12 | PIK3R1 | Sponge network | -4.997 | 0 | -0.892 | 0 | 0.369 |
71 | RP5-1165K10.2 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 1.401 | 0 | 3.368 | 0 | 0.367 |
72 | RP11-89K21.1 | hsa-let-7b-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-374b-5p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 4.915 | 0 | 3.368 | 0 | 0.364 |
73 | NUTM2A-AS1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-374b-5p;hsa-miR-486-5p | 12 | CCNA2 | Sponge network | 0.788 | 0 | 3.368 | 0 | 0.358 |
74 | AC004862.6 | hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-93-5p | 13 | PIK3R1 | Sponge network | -2.202 | 0.00081 | -0.892 | 0 | 0.357 |
75 | MAGI2-AS3 |
hsa-miR-103a-3p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-452-5p;hsa-miR-589-3p;hsa-miR-92a-3p;hsa-miR-93-3p | 11 | FGF2 | Sponge network | -1.801 | 0 | -1.086 | 0.00032 | 0.356 |
76 | LINC00648 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p | 11 | CCNA2 | Sponge network | 3.27 | 0.00013 | 3.368 | 0 | 0.351 |
77 | DNM1P35 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p | 12 | CCNA2 | Sponge network | 1.581 | 0 | 3.368 | 0 | 0.351 |
78 | POLR2J4 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 1.386 | 0 | 3.368 | 0 | 0.348 |
79 | RP11-341N2.1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 12 | CCNA2 | Sponge network | 3.431 | 0 | 3.368 | 0 | 0.347 |
80 | RP11-250B2.6 | hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-93-5p | 12 | PIK3R1 | Sponge network | -0.98 | 2.0E-5 | -0.892 | 0 | 0.342 |
81 | AP000473.5 | hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-338-5p | 11 | PIK3R1 | Sponge network | -1.157 | 0.00884 | -0.892 | 0 | 0.341 |
82 | TMEM161B-AS1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 1.593 | 0 | 3.368 | 0 | 0.336 |
83 | RP11-963H4.3 | hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-17-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-93-5p | 10 | PIK3R1 | Sponge network | -1.857 | 0.00116 | -0.892 | 0 | 0.328 |
84 | LINC00624 | hsa-let-7b-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 3.71 | 0 | 3.368 | 0 | 0.324 |
85 | RP11-407B7.1 | hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-188-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-338-5p;hsa-miR-582-5p;hsa-miR-629-3p;hsa-miR-93-5p | 13 | PIK3R1 | Sponge network | -0.818 | 0.00584 | -0.892 | 0 | 0.324 |
86 | RP11-166D19.1 |
hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-590-5p;hsa-miR-92a-3p | 11 | TGFBR2 | Sponge network | -0.244 | 0.28835 | -0.523 | 3.0E-5 | 0.324 |
87 | LINC00864 | hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-15b-5p;hsa-miR-185-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p | 10 | PIK3R1 | Sponge network | -3.954 | 0 | -0.892 | 0 | 0.322 |
88 | RP11-166D19.1 |
hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-15b-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p | 14 | PIK3R1 | Sponge network | -0.244 | 0.28835 | -0.892 | 0 | 0.32 |
89 | AC084219.4 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p | 11 | CCNA2 | Sponge network | 3.914 | 0 | 3.368 | 0 | 0.318 |
90 | TAPT1-AS1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 1.165 | 0 | 3.368 | 0 | 0.316 |
91 | RP1-179N16.6 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29b-1-5p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 1.955 | 0 | 3.368 | 0 | 0.311 |
92 | RP11-166D19.1 |
hsa-miR-103a-3p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-3p | 12 | FGF2 | Sponge network | -0.244 | 0.28835 | -1.086 | 0.00032 | 0.306 |
93 | AC073283.4 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 1.514 | 0 | 3.368 | 0 | 0.301 |
94 | LINC00885 | hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p | 10 | PIK3R1 | Sponge network | -4.686 | 0 | -0.892 | 0 | 0.3 |
95 | NOP14-AS1 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 1.279 | 0 | 3.368 | 0 | 0.295 |
96 | U91328.19 | hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 1.281 | 0 | 3.368 | 0 | 0.294 |
97 | MAGI2-AS3 |
hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-15b-5p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-93-5p | 13 | PIK3R1 | Sponge network | -1.801 | 0 | -0.892 | 0 | 0.294 |
98 | CASC2 |
hsa-miR-103a-3p;hsa-miR-155-5p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-421;hsa-miR-500a-5p;hsa-miR-501-5p | 11 | ARHGAP5 | Sponge network | -0.596 | 0.00187 | -0.391 | 8.0E-5 | 0.283 |
99 | AC005550.3 |
hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p | 10 | PIK3R1 | Sponge network | -2.571 | 0.00132 | -0.892 | 0 | 0.281 |
100 | RP11-7F17.3 | hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p | 11 | PIK3R1 | Sponge network | -0.873 | 0.00204 | -0.892 | 0 | 0.271 |
101 | SMIM2-AS1 |
hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-589-3p;hsa-miR-629-3p | 13 | PIK3R1 | Sponge network | -0.66 | 0.00587 | -0.892 | 0 | 0.27 |
102 | DANCR | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-199a-5p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p | 10 | CCNA2 | Sponge network | 1.387 | 0 | 3.368 | 0 | 0.269 |
103 | RP11-983P16.4 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 12 | CCNA2 | Sponge network | 0.673 | 0 | 3.368 | 0 | 0.266 |
104 | RP11-538D16.2 | hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-21-5p;hsa-miR-222-3p;hsa-miR-335-3p;hsa-miR-338-5p | 10 | FGF2 | Sponge network | 0.603 | 0.33218 | -1.086 | 0.00032 | 0.263 |
105 | AC068282.3 | hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-130a-3p;hsa-miR-22-3p;hsa-miR-27b-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-486-5p | 10 | CCNA2 | Sponge network | 0.933 | 6.0E-5 | 3.368 | 0 | 0.256 |
106 | RP11-685F15.1 | hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-454-3p;hsa-miR-93-5p | 10 | TGFBR2 | Sponge network | -9.951 | 0 | -0.523 | 3.0E-5 | 0.254 |